Clinical Trial Update: Effect of Veramyst and Olopatadine 0.2% Opthalmic Solution on Allergy Symptoms [Phase 4]

View source ↗

Summary

Phase 4 study assessing the effect of combining Veramyst nasal spray with olopatadine 0.2% ophthalmic solution for allergy symptoms in seasonal allergic rhiniti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• Olopatadine 0.2% Ophthalmic Solution (olopatadine hydrochloride)
• Veramyst (fluticasone furoate)

Snippet

Sponsor: University of Chicago | Conditions: Seasonal Allergic Rhinitis | Phase 4 | Status: COMPLETED | Results posted: 2013-07-17